XBiotech Inc.
XBIT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001626878
No open-market purchases or sales by XBiotech Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $4.56M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding XBiotech Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 38 | 39 | +1 |
| Shares | 3.34M | 3.45M | +105.6K (+3.2%) |
| Value | $14.0M | $13.8M | −$192.5K (−1.4%) |
New holders (4)
Institutions that held XBiotech Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| National Bank of Canada | 24,347 | $103.2K | 0.00% |
| Squarepoint Ops LLC | 18,922 | $75.7K | 0.00% |
| Jane Street Group, LLC | 16,327 | $65.3K | 0.00% |
| Tower Research Capital LLC (TRC) | 52 | $208 | 0.00% |
Sold out (3)
Institutions that held XBiotech Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Renaissance Technologies LLC | 15,287 | $63.0K |
| Group One Trading, L.P. | 1,738 | $7.16K |
| Advisor Group Holdings, Inc. | 50 | $206 |